Clinical Trials

Clinical trials are essential to evaluate the safety and effectiveness of therapies in a structured and carefully monitored way.

The clinical development program for tiratricol includes Phase II and Phase III studies, long-term follow-up and real-world data collection, contributing to a comprehensive understanding of its safety and efficacy.

Further information on ongoing and completed studies is available at:

https://clinicaltrials.gov/

Publications & Data

Scientific publications and clinical data support the responsible development of our therapies and contribute to the broader medical understanding of rare diseases. This section provides…

Explore